Supplemental Experimental Procedures

In vitro Voltage-Sensitive Dye Imaging (VSDI)
Changes in thalamocortical topography were evaluated in vitro using a previously described method (Barkat et al., 2011; Hackett et al., 2011) . The brain was quickly removed in chilled oxygenated artificial CSF (ACSF) containing (mM): 125 NaCl, 25 Glucose, 25 NaHCO 3 , 2.5 KCl, 2 CaCl 2 , 1.25 NaH 2 PO 4 and 1 MgCl 2 . The brain was sectioned perihorizontally (600µm, 15 o ) on a vibrating microtome (Leica Microsystems) to preserve the ventral medial geniculate (MGBv) and its projection to the auditory cortex, as previously described (Cruikshank et al., 2002) . Thalamocortical brain slices were incubated for 15 min at 35 o C, and then 90 minutes in the voltage-sensitive dye, Di-4-ANEPPS (Invitrogen D-1199, 5 µg/ml) at room temperature (20-22 o C). Six discrete sites in the MGBv spaced at 100µm intervals along the tonotopic latero-medial axis were activated with an ACSF-filled glass pipette. Stimulation (0.5 mA, 1 ms pulse) was delivered with a constant current stimulus isolator (Iso-Flex, A.M.P.I.) controlled by a programmable pulse generator (MiCam Ultima Software). Excitation light from a shuttered LED (BrainVision) was reflected toward the slice, and emitted fluorescence was imaged (1 ms frame rate; 512 ms period) with a Leica Plan APO 1.6x objective and a MiCam Ultima CMOS-based camera (SciMedia).
Fluorescent signals were integrated across regions of interest (130 x 130 µm) at a constant depth from the pia corresponding to upper layer 4 along the tonotopic rostro-caudal axis of A1, standardized across slices using an anatomical landmark (most rostral point of hippocampus). Individual time course traces were averaged across 10 trials and exported to Igor Pro (WaveMetrics) and Matlab (MathWorks) for analysis. Fluorescence change was normalized to resting fluorescence (∆F/F). Variations in intensity across MGBv stimulations were normalized by the maximum response within the white matter. Variations across daily preparations were normalized by dividing all signals by the maximum response within cortical L4 measured across all stimulation sites within a slice. Peak ∆F/F was defined as the maximum response across all L4 locations within A1. Topographic slopes for each animal were calculated as the linear relation of the position of peak ∆F/F along the rostro-caudal axis of A1 as a function of MGBv stimulation location. The acquisition and analysis of VSDI experiments were performed blind to the drug condition of the mouse pups.
Whole-cell patch-clamp recording
Thalamocortical brain slices were prepared as described above. Slices were first incubated in ACSF at 35°C for 30 min and subsequently maintained at room temperature for at least 1h before any electrophysiological recordings. The ACSF contained (in mM): 124 NaCl, 5 KCl, 1.25 NaH 2 PO 4 , 1.2 MgSO 4 , 26 NaHCO 3 , 2 CaCl 2 , and 10 glucose, pH 7.4. The slices were then transferred to a 2.5 ml recording chamber placed in an upright Nikon Eclipse E600FN microscope equipped with infrared and differential interference contrast imaging devices and superfused with oxygenized ACSF at room temperature (22-24°C).
Patch electrodes with a resistance of 3-6 M were prepared from borosilicate glass capillaries with a Flaming/Brown micropipette puller (Model P-87, Sutter Instruments Co., Novato, CA, USA). Pipette intracellular solution contained (in mM): 110 Cs-methanesulfonate, 10 TEA-Cl, 4 NaCl, 2 MgCl 2 , 10 EGTA, 10 HEPES, 4 ATPMg, and 0.3 GTP, with 5 QX-314 (N-(2,6-dimethylphenyl-carbamoylmethyl)-triethylammonium chloride) and creatine phosphokinase (17 unit/ml). Whole-cell voltage-clamp recordings were performed in L4 pyramidal neurons in A1 from P12-21 mice using an Axonpatch 200B amplifier (Axon Instruments, Molecular Devices) as previously described (Sun et al., 2013) . Series resistance was compensated 70-80% and monitored online. Recordings in which the series resistance was >25 MΩ and more than 15% change during the whole recording period were excluded from the data analysis. Signals were filtered at 2 KHz, digitized at 20 kHz by a Digidata 1320A interface, acquired by the pClamp 9.2 software, and analyzed with the Clampfit 9.2 program (Molecular Devices).
AMPAR sEPSCs were pharmacologically isolated by adding picrotoxin (60 µM) and D-AP-5 (50 µM) to the perfusion solution to block GABA A and NMDA receptors, respectively. Additional 1 µM TTX was added to the ACSF to record AMPAR mEPSCs. All sEPSCs and mEPSCs were confirmed visually for a monotonic rising phase and an approximately exponential decay phase. Minimally evoked EPSCs (eEPSCs) were elicited by stimulating the MGBv or L6. GABA A receptors were blocked with picrotoxin (60µM). Synaptic responses were first evoked around threshold stimulus. Then, stimulation intensity was adjusted to elicit detectable synaptic responses with about 50% failure rate to consecutive 20-100 trials of the same stimulus (Zhou et al., 2011) . To examine the postsynaptic silent synapses, cells were first held at -60mV, and then stimulated with the same intensity at +40mV. The failure responses of eEPSCs were visually verified blind to the drug condition of the mouse pups. The successful responses of eEPSCs were confirmed to have a fast rising phase and a slow decay phase with amplitude at least three times the root mean squares noise (Sun et al., 2013) . The fraction of silent synapses was calculated using the established formula: % of silent synapses = (1-ln(F -60 )/ln(F +40 )) x100%.
